<DOC>
	<DOCNO>NCT00572468</DOCNO>
	<brief_summary>This randomized trial compare effect oral simvastatin versus placebo target mevalonate pathway men undergo prostatectomy plan management prostate cancer . Observed tissue effect correlate change serum cholesterol low-density lipoprotein .</brief_summary>
	<brief_title>Statin Therapy Versus Placebo Prior Prostatectomy</brief_title>
	<detailed_description>Prostate cancer patient choose undergo prostatectomy primary treatment option recruit trial . Forty-four subject randomize either placebo simvastatin ( 40 mg po/day ) 4 week prior surgery . Serum sample obtain baseline immediately prior prostatectomy . At prostatectomy , cancerous benign prostate tissue microdissected cryopreserved . Archival prostatectomy tissue use construct tissue microarrays contain match benign malignant section . The effect HMG-CoA reductase inhibition lipid raft cholesterol content target prenylation determine . The incidence apoptosis determine along protein level mediator apoptosis . Lastly effect statin therapy cellular marker proliferation determine . Previously , study effect statin use risk prostate cancer detection case-control study Portland VA Medical Center . Statin use associate 62 % reduction cancer odds-risk ( OR = 0.38 , 95 % CI 0.21-0.69 ) . Although epidemiologic laboratory finding generate enthusiasm study statins prostate cancer , study examine biologic effect statins prostate cancer human . Hypothesis : Statin therapy prior prostatectomy successfully target mevalonate pathway human prostate intervention favorably alter tumor biomarker status .</detailed_description>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Histologically confirm prostatic adenocarcinoma Gleason 5 7 ( 3+4 = 7 accept , 4 + 3 = 7 ) Radical prostatectomy choose primary treatment prostate cancer Age 18 year old Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Other preoperative prior treatment direct prostate cancer ( i.e. , Radiation , hormonal therapy , cryotherapy ) Significant active medical illness opinion investigator would preclude protocol treatment History active liver disease abnormal result baseline liver function test ( &gt; 2 x normal ) Current use : simvastatin lovastatin HMGCoA inhibitor lipidlowering agent Amiodarone Cholestyramine Cholestyramine colestipol ( bile acid sequestrants ) Clofibrate fenofibrate Cyclosporine CYP3A4 inhibitor Danazol Diltiazem Gemfibrozil Niacin ( 1 g/day ) Verapamil Warfarin Known allergy sensitivity ingredient simvastatin</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>cancer</keyword>
	<keyword>pre-operative surgery</keyword>
	<keyword>prostate</keyword>
	<keyword>prostatectomy</keyword>
	<keyword>radiation</keyword>
</DOC>